CI Investments Inc’s DexCom DXCM Stock Holding History

CI Investments Inc’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14,022	Closed	-$888K	–	639
2025 Q4	$888K	Buy	+14,022	New	+$907K	﹤0.01%	446

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

CI Investments Inc's DXCM Position: Q2 2026 in Review

CI Investments Inc increased its DexCom (DXCM) stake by 48% in Q2 2026, buying an estimated $27.7M and bringing the position to 1,287,663 shares worth $86.7M. The position accounts for 0.28% of the portfolio, ranked #71.

CI Investments Inc first reported a position in DXCM in Q3 2019 and has held it in 28 quarters since. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

CI Investments Inc held 1,287,663 shares of DexCom worth $86.7M as of Q2 2026.
CI Investments Inc bought 415,085 DexCom shares in Q2 2026, an estimated $27.7M.
DexCom made up 0.28% of CI Investments Inc's portfolio in Q2 2026, its #71 holding.
CI Investments Inc first reported a position in DexCom in Q3 2019 and has held it in 28 quarters since.
976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on CI Investments Inc's 13F filing for Q2 2026, filed 13 Aug 2026.